Literature DB >> 1341040

Regulation of myosin heavy chain and actin isogenes during cardiac growth and hypertrophy.

K Schwartz1, L Carrier, C Chassagne, C Wisnewsky, K R Boheler.   

Abstract

Expression of myosin heavy chain (MHC) and actin multigene families changes in mammals during cardiac growth and hypertrophy, but whether or not there is a common regulatory pathway is unclear. To address this question, we have looked at the alpha- and beta-MHC, and at the alpha-skeletal and alpha-cardiac actin (alpha-skel act and alpha-card act) isomRNA transitions during development and senescence, both in rat and human hearts. Since the precise amounts of each isoactin mRNA were not precisely known in the above situations, we first analyzed the time- course of accumulations of the two sarcomeric transcripts by primer extension assays, which allow an umambiguous quantification of the ratios of the two actin transcripts. In rats, both isogenes are expressed in-utero. alpha-skel act represents 40% of the total one week after birth, remains constant for 3 weeks, decreases to less than 5% at two months and does not re-accumulate thereafter. In humans, in contrast, alpha-skel act represents < 20% in-utero and in neonates, increases to 48% during the first decade after birth and becomes the predominant isoform of adult hearts. In rats beta-MHC mRNAs accumulate at birth, become undetectable at 3 weeks and reaccumulate to as much as 80% during senescence, and in humans beta-MHC mRNAs predominate throughout all developmental stages. These data show that in both species, the multigene families encoding the major contractile proteins are not coordinately regulated during development and aging.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341040

Source DB:  PubMed          Journal:  Symp Soc Exp Biol        ISSN: 0081-1386


  9 in total

1.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

Authors:  W K Jones; I L Grupp; T Doetschman; G Grupp; H Osinska; T E Hewett; G Boivin; J Gulick; W A Ng; J Robbins
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 2.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

3.  The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.

Authors:  Domenico M Taglieri; Keven R Johnson; Brian T Burmeister; Michelle M Monasky; Matthew J Spindler; Jaime DeSantiago; Kathrin Banach; Bruce R Conklin; Graeme K Carnegie
Journal:  J Mol Cell Cardiol       Date:  2013-10-23       Impact factor: 5.000

4.  Regulation of expression of contractile proteins with cardiac hypertrophy and failure.

Authors:  X J Martin; D G Wynne; P E Glennon; A F Moorman; K R Boheler
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

5.  Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain.

Authors:  Kumar Pandya; Kristine Porter; Howard A Rockman; Oliver Smithies
Journal:  Eur J Heart Fail       Date:  2009-07       Impact factor: 15.534

6.  Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.

Authors:  Keven R Johnson; Jessie Nicodemus-Johnson; Mathew J Spindler; Graeme K Carnegie
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

7.  Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart.

Authors:  A van der Pol; M F Hoes; R A de Boer; P van der Meer
Journal:  J Intern Med       Date:  2020-06-17       Impact factor: 8.989

8.  Proposed regulation of gene expression by glucose in rodent heart.

Authors:  Martin E Young; Jie Yan; Peter Razeghi; Robert C Cooksey; Patrick H Guthrie; Stanislaw M Stepkowski; Donald A McClain; Rong Tian; Heinrich Taegtmeyer
Journal:  Gene Regul Syst Bio       Date:  2007-11-05

9.  Developmental increase in β-MHC enhances sarcomere length-dependent activation in the myocardium.

Authors:  Sherif M Reda; Sampath K Gollapudi; Murali Chandra
Journal:  J Gen Physiol       Date:  2019-01-02       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.